Shabber Mohammed
6PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 06, 2025
Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with <i>In Vitro</i> and <i>In Vivo</i> Antitumor Efficacy in Triple-Negative Breast Cancer.Shabber Mohammed, Shabu Thakur, Diksha Manhas
|Aug 14, 2025
Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma.Emma J Hoelzen, Hanna S Radomska, Samuel K Kulp
|Aug 01, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.Shu Ning, Cameron M Armstrong, Enming Xing
|May 19, 2023
Aryl Methyl Ketones: Versatile Synthons in the Synthesis of Heterocyclic Compounds.Shabber Mohammed, Jason S West, Mark J Mitton-Fry
|Feb 21, 2022
Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties.Radhika Amaradhi, Shabber Mohammed, Avijit Banik
|Jan 07, 2020
Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models.Radhika Amaradhi, Avijit Banik, Shabber Mohammed
Pageof 1
Frequent Collaborators
2 joint publications
Thota Ganesh
1 joint publications
Asheebo Rojas
1 joint publications
Damoder Reddy Motati
1 joint publications
Jason S West
1 joint publications
Shu Ning
1 joint publications
Cameron M Armstrong
1 joint publications
Enming Xing
1 joint publications
Amy R Leslie
1 joint publications
Richard Y Gao
1 joint publications
Masuda Sharifi
